Skip to main content
. Author manuscript; available in PMC: 2014 Aug 8.
Published in final edited form as: N Engl J Med. 2013 Jun 2;369(2):134–144. doi: 10.1056/NEJMoa1305133

Table 2. Drug-Related Adverse Events*.

Drug-Related Event All Grades (N = 135) Grade 3 or 4 (N = 135)
number (percent)
Any 107 (79) 17 (13)

Hypothyroidism 11 (8) 1 (1)

Gastrointestinal disorder
 Diarrhea 27 (20) 1 (1)

 Nausea 13 (10) 0

 Abdominal pain 7 (5) 1 (1)

Generalized symptom
 Fatigue 41 (30) 2 (1)

 Myalgia 16 (12) 0

 Headache 14 (10) 0

 Asthenia 13 (10) 0

 Pyrexia 10 (7) 0

 Chills 9 (7) 0

 Decreased appetite 6 (4) 1 (1)

Increase in aminotransferase level
 AST 13 (10) 2 (1)

 ALT 11 (8) 0

Renal failure 3 (2) 2 (1)

Respiratory disorder
 Cough 11 (8) 0

 Dyspnea 6 (4) 0

 Pneumonitis 6 (4) 0

Skin disorder
 Rash 28 (21) 3 (2)

 Pruritus 28 (21) 1 (1)

 Vitiligo 12 (9) 0
*

Included are drug-related adverse events that occurred in at least five patients or drug-related grade 3 or 4 adverse events that occurred in at least two patients. ALT denotes alanine aminotransferase, and AST aspartate aminotransferase.